Day: March 29, 2021

LONDON, March 29, 2021 – Stolt-Nielsen Limited (Oslo Børs: SNI) will host a video conference to present the Company’s unaudited results for the first quarter of 2021 on Thursday, April 8, 2021 at 15:00 CEST (09:00 EST, 14:00 BST). The presentation and video conference will be hosted by: –           Mr. Niels G. Stolt-Nielsen – Chief Executive Officer, Stolt-Nielsen Limited–           Mr. Jens F. Grüner-Hegge – Chief Financial Officer, Stolt-Nielsen Limited Those who wish to watch the live broadcast may access it here The presentation will be published on our website:https://www.stolt-nielsen.com/en/investors/reports-presentations/ For additional information please contact: Jens F. Grüner-HeggeChief Financial OfficerUK +44 (0) 20 7611 8985j.gruner-hegge@stolt.com Ellie DavisonHead of Corporate CommunicationsUK +44...

Mise à disposition des documents préparatoires à l’assemblée générale ordinaire annuelle et extraordinaire Paris, le 29 mars 2021, à 12h Compte tenu des décisions gouvernementales liées à la crise sanitaire COVID 19, GROUPE PARTOUCHE informe ses actionnaires que son Assemblée Générale mixte se tiendra à huis clos, hors la présence physique des actionnaires, le mercredi 14 avril 2021 à 10 heures au siège social de la société sis 141bis rue de Saussure 75017 PARIS L’avis de réunion comportant l’ordre du jour et les projets de résolutions a été publié le 10 mars 2021 au Bulletin des Annonces Légales Obligatoires (BALO). Les modalités de participation et de vote à cette Assemblée figurent également dans le même avis.Les documents et renseignements prévus aux articles R. 225-73, R. 225-81, et R. 225-83 du Code de commerce...

RANCHO CUCAMONGA, Calif., March 29, 2021 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company’s Abbreviated New Drug Application (“ANDA”) for Dextrose injection 50% in the 50 mL Luer-Jet® Prefilled Syringe System. For the past 40 years, the company has sold and marketed the product under the “grandfather” exception to the FDA’s “Prescription Drug Wrap-Up” program. Net revenues for the Company’s Dextrose injection for the year ended December 31, 2020, were $7.6 million. Amphastar’s CEO and President, Dr. Jack Zhang, commented: “The FDA’s approval of Dextrose, a product often on the Agency’s Drug Shortage list, offers an opportunity to ensure quality products are produced at the highest standard and highlights Amphastar’s manufacturing capabilities...

ISS Says the Dissident Plan Is “Light on Details,” that the Dissidents “Do Not Appear to Have an Executive Team in Place to Run the Company,” and that Shareholders Would be Best Served by “Preventing Them from Obtaining Control” Taronis Board Previously Engaged in Settlement Discussions Consistent with ISS Recommendations but the Activist Group Refuses to Negotiate any Settlement that Does Not Include Control of the Board Taronis Board Urges Shareholders to IGNORE any WHITE Consent Solicitation Card and Reject the Activist Group’s Attempts to Disrupt the Company’s Positive Momentum Peoria, AZ, March 29, 2021 (GLOBE NEWSWIRE) — Taronis Fuels, Inc. (“Taronis” or “the Company”) (OTCQB:TRNF), a global producer of renewable and socially responsible fuel products, responded to a report issued by Institutional Shareholder Services (“ISS”)...

VANCOUVER, British Columbia , March 29, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Hunter Technology Corp. (TSX-V: HOC; OTCQB: HOILF; WKN: A2QEYH, FSE: RWPM, ISIN: CA4457371090) (“Hunter” or the “Company”) is pleased to announce that its OilEx Platform is now live for market testing. Ahead of the execution of live pilot transactions for selected hydrocarbon producers and purchasers, targeted for the end of Q2 2021, the Company is leveraging its robust solution development progress into live market testing with senior advisers and prospective users. To ensure vigorous testing of the Platform by all participants in the hydrocarbon value chain, testing will be open to oil trading veterans, industry experts, independent producers, purchasers and brokers. The limited release of the OilEx Platform includes five core functions of the platform:purchaser...

Press release, 29 March, 2021 Coloplast, a global medical device company and market leader in intimate healthcare, has been awarded a contract for ostomy products with Vizient, Inc., the largest healthcare performance improvement company in the US. “I am excited about the agreement with Vizient and the potential it holds for our company, for Vizient members and for the many people living with an ostomy in the US. This agreement will strengthen our presence across hospitals and other healthcare organizations and enable us to provide our products and services to more and more users in the US,” says President & CEO of Coloplast, Kristian Villumsen. The new agreement allows Vizient members access with contracted pricing to Coloplast’s full portfolio of ostomy products, including ostomy pouches and supporting products. “We are delighted...

Pressemeddelelse, 29. marts, 2021 Coloplast har vundet en treårig aftale og skal nu levere stomiprodukter via USA’s største indkøbsorganisation Vizient Inc. “Jeg er meget glad for aftalen med Vizient og det potentiale, den rummer for vores selskab, for Vizients medlemmer og for de mange mennesker, der lever med stomi i USA. Aftalen vil styrke vores tilstedeværelse på hospitaler og andre sundhedscentre og give os mulighed for at levere vores produkter og services til flere og flere amerikanske brugere”, udtaler Coloplasts administrerende direktør, Kristian Villumsen. Den nye aftale giver Vizients medlemmer adgang til Coloplasts fulde portefølje af stomiprodukter. “Vi er meget begejstrede over nu at være en del af Vizients portefølje af stomiprodukter. Vizients mission er at hjælpe deres medlemmer med at levere kvalitetspleje...

Shareholders in Sbanken ASA are hereby invited to attend the Ordinary General Meeting to be held at 10.00 hours (CET) on 22 April 2021 at Sbanken’s premises in Folke Bernadottes vei 38, Fyllingsdalen, Bergen, Norway. Important message regarding the coronavirus pandemic:Shareholders are encouraged not to attend in person the general meeting, but instead vote electronically in advance or by granting a proxy to the Chair of the Board of Directors according to the instructions provided in the notice. The agenda includes approval of the 2020 Annual Report and accounts, including proposed dividend authorisation to the Board of Directors, election of members of the Board of Directors and Nomination Committee, as well as approval of remuneration for members of these bodies. The Board of Directors also asks the General Meeting for authorization...

Aksjonærene i Sbanken ASA innkalles til ordinær generalforsamling torsdag 22. april 2021 kl. 10:00 i bankens lokaler i Folke Bernadottes vei 38, Fyllingsdalen, Bergen. Viktig melding angående koronaviruspandemien:Aksjonærer oppfordres i år til å ikke møte fysisk på generalforsamlingen, men til å avgi forhåndsstemme elektronisk eller gi fullmakt til styreleder med eller uten stemmeinstruks etter den fremgangsmåte som følger av innkallingen. Til behandling foreligger godkjenning av årsregnskap og årsberetning for 2020, herunder beslutning av tildeling av utbyttebyttefullmakt til styret, valg av styre og valgkomite, samt fastsettelse av godtgjørelse for disse. Styret ber også generalforsamlingen om fullmakt til å erverve egne aksjer, fullmakt til å forhøye aksjekapitalen ved nytegning av aksjer, samt fullmakt til å utstede fondsobligasjonslån,...